{"name":"Huahui Health","slug":"huahui-health","ticker":"","exchange":"","domain":"huahuihealth.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPQklBNHhZT21DZnRPN29vQmsxM2hmSk5iUGZDaURhZmtEZnBkb2pSY0sycFZ6cklSczAzRktJb09PQUUzbDBPZV9QYXU5czNPbThuckFRakx2dXAxZ0pWcUhDcEh2WXF0NXlhY2VIa0VIdjVIYkctcFd0cTh4NXcxZWNzUUZaaG82VS1oVWFRVzlrM01DTTIxZGszSVRCbHlQSjFKYTFENWNuQVlUdGFhY1VZLUkxTGFBU3VFdi1xN3BEMVhob2dTbVhMNlloUGVESUtqdFFwMWdZdzFKZU9pUm5BSUxKYXdsa29renJtYVVnQU5mSlI5YTNiaw?oc=5","date":"2026-04-07","type":"trial","source":"Mena FN","summary":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead The Charge In Pioneering New Treatments Delveinsight - Mena FN","headline":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead The Charge In Pioneering New Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOV2hHRE1LeE8tRndRQ1pXMDFGMFFyRXpCUHJZSnlLdHk2U1NPNWtScHFNTnhIMzRlNEZHMEJydEYtUkZTcjV0d242MFRGWHVGMkpRejJZTDFmWHZycGhiR1A1cndqeFg1UFEydWR0ek5FblNLa3RkYUZJMjg0UjhKRWE4elRiUG5RajExWGlMVjU4eFo4WVg5dw?oc=5","date":"2026-02-25","type":"pipeline","source":"The Pharma Letter","summary":"Strong potential for Huayunuo in viral hepatitis - The Pharma Letter","headline":"Strong potential for Huayunuo in viral hepatitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPWEJXcmt3ZDNhTE1sTmdFakN0RElWLWJJV2diT3dYaUoxS1hadVk2ZkF5RmJ4eFVaQTRqWmdHWGt1Z3pwVGQtejg0SWltWTM5NnhRR1ZRVnFPNWJ1em9HOXlpLWxKc2wyclpUVkxUSVZSRmxvQUlrTmREQjdhOUxYQkg5MkpZT0dPQlhEYlpZa1JSMFJWa0IxQ1RmdkJueDYxdWYxb0FkVlgwMTU3ODJr?oc=5","date":"2026-01-31","type":"deal","source":"thediplomaticinsight.com","summary":"Pakistan Backs Huahui Health–Local Pharma Partnership to Tackle Hepatitis Delta - thediplomaticinsight.com","headline":"Pakistan Backs Huahui Health–Local Pharma Partnership to Tackle Hepatitis Delta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOcnZsYnJQSlFoVm5UWmYtV1otdDZuZ2JuYkM3RV9FdDRTSFVQeW1IbW5XMHJBbDczeW53REZkVlVCVGJxMVd5eGVJNjZaYVFXTVJIN1VKb2FVX3kybDh3T2JUT3pVSE45LWM2UzFULW1UOHRMMDJqUTdyRUxPcVhIMmM2WExVR0FqcVpQVDl4Ykk4YlQyLVU2ZnBYMmRwa03SAacBQVVfeXFMTUhQcVVoTnZVOVZPbHozSFdUX2tGUG1WYnQtRU0teWtTYVlkUkxkUjYxOFZXWW9qV0ZwZ253WUFvaWhIQV9oV3pYQzExSkVJUVlWelFlVHRpYnRVT1VKSDhUMXllWXREYkdHZ2owZzNkSEFtekt2Z3VNaW9OLTQxYlJzREItYW9GcFdNRXBEWC1JRDA0TjhaWlVCZTRhU2NoTDRMTGhKcWs?oc=5","date":"2026-01-30","type":"deal","source":"The Express Tribune","summary":"Pakistan eyes China partnership as hepatitis delta cases rise - The Express Tribune","headline":"Pakistan eyes China partnership as hepatitis delta cases rise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPSFY2bTVMZ01FckNZeUk1cWx1dXFWeGs5SGN5UGI2dWU5RzctMDlpRWJMNVlmeGwtTkN3cWZrVWl5S3F1OERqUnVoX3hsd0owRGdwaGZoUmJtQ1VLeWtvMk4tSVRsV0hJUUg1SWpLYVRvMjJWWW01NzI5dVFfTVBxNThrYWlhM1F5Z1k1VEF1TU5GazVMWkVPbkNuU3RUbjJ0azdSQ05WNjZEV2xwWmhzSXMtRXd5b0FRa01qcUpVeGtXTXJQRVNqM2tkQ0l5WExvaHlObHpVRXAtQQ?oc=5","date":"2026-01-28","type":"regulatory","source":"BioPharma APAC","summary":"China Approves First Ever Therapy For Chronic Hepatitis D With Conditional Clearance For Libevitug - BioPharma APAC","headline":"China Approves First Ever Therapy For Chronic Hepatitis D With Conditional Clearance For Libevitug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdnJ3bUtvcnBTSVZpU1lyYTBhbDFxYTYzUzdfYzgwQWZkTTNObXgxWjRUbkxsemlpRDBPY0xDc3lFUG95T2hCNGZ0YmVObEhFRThudkp3SVFsY05HRlN5VUdPMXlCaDZmTENhWTNUb195WG13aE9iRmtHVEk1enp3NE9LTlF5eW90Tk9EbVhuV25pQ1hVUFFITl8zMnJodE9u?oc=5","date":"2026-01-27","type":"regulatory","source":"The Pharma Letter","summary":"China approves first hepatitis D treatment, from Huahui - The Pharma Letter","headline":"China approves first hepatitis D treatment, from Huahui","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQNkRmWEVIX2FWSDU0RGtmUFZYcVJIRHdIcWNZV0hRcmlqWFNfWWdlRzd2NFBPa1JEdXM3LVZYcS1TUThNdFk3NU81UTVieW9wLW5hZEtLYmN5MnhGYWZVR0tKOVk0ZmRTSHZBcnpzeXRUcVlrN1ozNkJiT2xXZHNyNTFWTQ?oc=5","date":"2026-01-27","type":"pipeline","source":"pharmaphorum","summary":"China clears its first drug for chronic hepatitis D - pharmaphorum","headline":"China clears its first drug for chronic hepatitis D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE55ekl2aXpyUHIzd2k3QUc0bF91ZWFhUTR1LU0ybGtGamUyV2FBcFotdnk0TlN0aWlLTHowUVNuMDZiQm9xZVFPNGVkQ0RrWXVFMFRzR2JMTkFSSnVSTmt6dnQ3RFNudUtGUnFrcm5kMEFaRDRTWmo1WW9kcFJOUQ?oc=5","date":"2021-10-21","type":"pipeline","source":"Global Venturing","summary":"Huahui Health treats itself to $78m - Global Venturing","headline":"Huahui Health treats itself to $78m","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}